Correlations between motor persistence and plasma levels in methylphenidate-treated boys with ADHD
- PMID: 11466170
- DOI: 10.1017/S1461145701002413
Correlations between motor persistence and plasma levels in methylphenidate-treated boys with ADHD
Abstract
Following a 0.9 mg/kg methylphenidate loading dose, serial plasma level determinations, self-scored mood ratings, and measures of motor persistence were gathered on eight previously unmedicated boys with attention deficit disorder with hyperactivity (ADHD) during a 9-h period. The measures were repeated using the same loading dose after 6 months of maintenance treatment with methylphenidate (1.3 mg/kg x d). Kinetic-dynamic modelling suggests inverse correlative relationships between motor performance errors and plasma levels. Pharmacokinetic parameters did not change between acute and maintenance drug treatment phases, and there was no evidence of long-term tolerance.
Similar articles
-
First-Dose Methylphenidate-Induced Changes in Brain Functional Connectivity Are Correlated With 3-Month Attention-Deficit/Hyperactivity Disorder Symptom Response.Biol Psychiatry. 2017 Nov 1;82(9):679-686. doi: 10.1016/j.biopsych.2017.03.022. Epub 2017 Apr 5. Biol Psychiatry. 2017. PMID: 28465019
-
Boys with attention-deficit/hyperactivity disorder perform wider and fewer finger tapping than typically developing boys - Peer comparisons and the effects of methylphenidate from an exploratory perspective.Brain Dev. 2022 Mar;44(3):189-195. doi: 10.1016/j.braindev.2021.11.002. Epub 2021 Dec 2. Brain Dev. 2022. PMID: 34865917
-
Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS Formulation.Ther Drug Monit. 2015 Jun;37(3):347-52. doi: 10.1097/FTD.0000000000000149. Ther Drug Monit. 2015. PMID: 25384118
-
Serum and brain concentrations of methylphenidate: implications for use and abuse.Neurosci Biobehav Rev. 2003 Nov;27(7):615-21. doi: 10.1016/j.neubiorev.2003.08.013. Neurosci Biobehav Rev. 2003. PMID: 14624806 Review.
-
[Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].Psychiatr Pol. 2009 Mar-Apr;43(2):183-92. Psychiatr Pol. 2009. PMID: 19697788 Review. Polish.
Cited by
-
The NICE ADHD health technology assessment: a review and critique.Child Adolesc Psychiatry Ment Health. 2008 Jan 15;2(1):1. doi: 10.1186/1753-2000-2-1. Child Adolesc Psychiatry Ment Health. 2008. PMID: 18197978 Free PMC article.
-
Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder.Psychopharmacology (Berl). 2004 Sep;175(3):319-30. doi: 10.1007/s00213-004-1833-7. Psychopharmacology (Berl). 2004. PMID: 15138760 Clinical Trial.
-
Transdermal patches: history, development and pharmacology.Br J Pharmacol. 2015 May;172(9):2179-209. doi: 10.1111/bph.13059. Epub 2015 Mar 18. Br J Pharmacol. 2015. PMID: 25560046 Free PMC article. Review.
-
Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data.BMC Psychiatry. 2004 Sep 30;4:28. doi: 10.1186/1471-244X-4-28. BMC Psychiatry. 2004. PMID: 15458569 Free PMC article. Clinical Trial.
-
[The health economics of attention deficit hyperactivity disorder in Germany. Part 2: Therapeutic options and their cost-effectiveness].Nervenarzt. 2010 Mar;81(3):301-14. doi: 10.1007/s00115-009-2889-8. Nervenarzt. 2010. PMID: 19936695 German.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical